Union Sues AbbVie Over Humira Patents

Drug Industry Daily
A A
A New York union has filed a class-action lawsuit against AbbVie and seven other drugmakers, accusing them of throwing up a “patent thicket” to keep cheaper rivals to AbbVie’s blockbuster drug Humira off the market.

To View This Article:

Login

Subscribe To Drug Industry Daily